Evofosfamide: Additional Phase I/II data

Data from 18 evaluable patients with relapsed and/or refractory MM in the Phase II portion of an open-label, U.S. Phase I/II trial showed that IV evofosfamide plus low-dose dexamethasone and Velcade ...